392 related articles for article (PubMed ID: 28088237)
1. Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis.
Tegegne BS; Habtewold TD; Mengesha MM; Burgerhof JG
Syst Rev; 2017 Jan; 6(1):6. PubMed ID: 28088237
[TBL] [Abstract][Full Text] [Related]
2. Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis.
Tegegne BS; Mengesha MM; Teferra AA; Awoke MA; Habtewold TD
Syst Rev; 2018 Oct; 7(1):161. PubMed ID: 30322409
[TBL] [Abstract][Full Text] [Related]
3. Global prevalence of diabetes mellitus in patients with tuberculosis: a systematic review and meta-analysis protocol.
Tankeu AT; Bigna JJ; Nansseu JR; Endomba FTA; Wafeu GS; Kaze AD; Noubiap JJ
BMJ Open; 2017 Jun; 7(6):e015170. PubMed ID: 28601832
[TBL] [Abstract][Full Text] [Related]
4. HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis.
Sultana ZZ; Hoque FU; Beyene J; Akhlak-Ul-Islam M; Khan MHR; Ahmed S; Hawlader DH; Hossain A
BMC Infect Dis; 2021 Jan; 21(1):51. PubMed ID: 33430786
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of therapeutic outcomes of multidrug resistant tuberculosis and their predictors in adults receiving integrated treatment of tuberculosis and human immuno-deficiency virus in low- and middle-income countries: a study protocol.
Kadia BM; Aroke D; Njefi KP; Tochie JN; Tianyi FL; Kadia RS; Dimala CA
Syst Rev; 2020 Oct; 9(1):228. PubMed ID: 33023668
[TBL] [Abstract][Full Text] [Related]
6. Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis.
Gautam S; Shrestha N; Mahato S; Nguyen TPA; Mishra SR; Berg-Beckhoff G
Sci Rep; 2021 Jan; 11(1):2113. PubMed ID: 33483542
[TBL] [Abstract][Full Text] [Related]
7. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis.
Hayashi S; Chandramohan D
Trop Med Int Health; 2018 Oct; 23(10):1058-1070. PubMed ID: 30062731
[TBL] [Abstract][Full Text] [Related]
8. Incidence and predictors of acquired resistance to second-line antituberculosis drugs during the course of multi-drug resistant tuberculosis treatment: protocol for a systematic review and meta-analysis.
Alemu A; Bitew ZW; Diriba G; Gashu E; Seid G; Eshetu K; Kebede A; Gumi B
BMJ Open; 2023 Apr; 13(4):e070143. PubMed ID: 37019479
[TBL] [Abstract][Full Text] [Related]
9. Protocol for a systematic review of long-term physical sequelae and financial burden of multidrug-resistant and extensively drug-resistant tuberculosis.
Akalu TY; Clements ACA; Baraki AG; Alene KA
PLoS One; 2023; 18(5):e0285404. PubMed ID: 37186609
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis.
Liu Q; Li W; Xue M; Chen Y; Du X; Wang C; Han L; Tang Y; Feng Y; Tao C; He JQ
Sci Rep; 2017 Apr; 7(1):1090. PubMed ID: 28439071
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review.
Workneh MH; Bjune GA; Yimer SA
PLoS One; 2017; 12(4):e0175925. PubMed ID: 28430796
[TBL] [Abstract][Full Text] [Related]
12. Association between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis.
Mesfin YM; Hailemariam D; Biadgilign S; Kibret KT
PLoS One; 2014; 9(1):e82235. PubMed ID: 24416139
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of chronic obstructive pulmonary disease in the global HIV-infected population: a systematic review and meta-analysis protocol.
Bigna JJ; Kenne AM; Asangbeh SL
Syst Rev; 2017 Mar; 6(1):68. PubMed ID: 28356123
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis.
Xu G; Hu X; Lian Y; Li X
BMC Infect Dis; 2023 Nov; 23(1):813. PubMed ID: 37986146
[TBL] [Abstract][Full Text] [Related]
15. Burden of drug-resistant tuberculosis among contacts of index cases: a protocol for a systematic review.
Akalu TY; Clements ACA; Gebreyohannes EA; Wolde HF; Shiferaw FW; Alene KA
BMJ Open; 2024 Jan; 14(1):e074364. PubMed ID: 38195168
[TBL] [Abstract][Full Text] [Related]
16. Sequelae of multidrug-resistant tuberculosis: protocol for a systematic review and meta-analysis.
Alene KA; Clements ACA; McBryde ES; Jaramillo E; Lonnroth K; Shaweno D; Viney K
BMJ Open; 2018 Feb; 8(2):e019593. PubMed ID: 29440162
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of intransient TB-induced hyperglycaemia in previously undiagnosed diabetes mellitus 2 individuals: a protocol for a systematic review and meta-analysis.
Menon S; Francis J; Zdraveska N; Dusabimana A; Bhattacharyya S
Syst Rev; 2019 Sep; 8(1):234. PubMed ID: 31511077
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus comorbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review.
Lutfiana NC; van Boven JFM; Masoom Zubair MA; Pena MJ; Alffenaar JC
Br J Clin Pharmacol; 2019 Jul; 85(7):1407-1417. PubMed ID: 30908689
[TBL] [Abstract][Full Text] [Related]
19. Impact of diabetes on treatment outcomes and long-term survival in multidrug-resistant tuberculosis.
Kang YA; Kim SY; Jo KW; Kim HJ; Park SK; Kim TH; Kim EK; Lee KM; Lee SS; Park JS; Koh WJ; Kim DY; Shim TS
Respiration; 2013; 86(6):472-8. PubMed ID: 23689646
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis.
Ambachew S; Eshetie S; Geremew D; Endalamaw A; Melku M
Syst Rev; 2019 Feb; 8(1):60. PubMed ID: 30803444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
